|
CN101146514A
|
|
Drugs with improved hydrophobicity for incorporation in medical devices
|
|
WO2005123142A1
|
|
A method using inorganic nanoparticles as non-viral vectors for gene therapy
|
|
WO2005062991A2
|
|
Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
|
|
WO2004100935A2
|
|
Propofol formulation containing reduced oil and surfactants
|
|
US2003133955A1
|
|
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US2003068362A1
|
|
Methods and formulations for the delivery of pharmacologically active agents
|
|
US2003073642A1
|
|
Methods and formulations for delivery of pharmacologically active agents
|
|
CN1638736A
|
|
Composition and methods for treatment of hyperplasia
|
|
US6753006B1
|
|
Paclitaxel-containing formulations
|
|
US6537579B1
|
|
Compositions and methods for administration of pharmacologically active compounds
|
|
CA2371912A1
|
|
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
EP1685835A2
|
|
Long term administration of sub-therapeutic dose levels of pharmacologically active agents
|
|
EP1171117A1
|
|
Long term administration of pharmacologically active agents
|
|
US6528067B1
|
|
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6749868B1
|
|
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
EP1683517A1
|
|
Methods for the production of protein particles useful for delivery of pharmacological agents
|
|
US5997904A
|
|
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6565842B1
|
|
Crosslinkable polypeptide compositions
|
